Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00473915 · ClinicalTrials.gov registry record · Phase 4

Intranasal Steroids and the Nasal Ocular Response

A Phase 4 study of Seasonal Allergic Rhinitis, sponsored by University of Chicago.

Completed
Registry status
Phase 4
Development phase
20
Enrollment target
1
Study location

NCT00473915: Completed Phase 4 study of Seasonal Allergic Rhinitis, sponsored by University of Chicago.

NCT00473915 is a Phase 4 study of Seasonal Allergic Rhinitis that has completed, run by University of Chicago. The registered enrollment target is 20 participants, below the 667-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00473915, a Phase 4 study of Seasonal Allergic Rhinitis, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
Phase 4
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Eye symptoms of tearing, redness and itch frequently occur in patients with allergic rhinitis or hayfever. The purpose of this study is to learn whether placing allergen (the substance that causes allergies) in the nose several days in a row will cause an increase in eye symptoms and whether receiving a nasal steroid spray will prevent these eye symptoms.

Conditions Studied

Seasonal Allergic Rhinitis

Interventions

  • DRUG fluticasone furoate

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2007-04
Est. Completion 2008-02
Phase Phase 4
University of Chicago

796 total trials

What the finished NCT00473915 record still lists

NCT00473915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 667-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Seasonal Allergic Rhinitis appearing as the primary indexed condition, and to 1 intervention - of which fluticasone furoate is the first listed.

NCT00473915 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00473915 about?

NCT00473915 is a clinical study titled "Intranasal Steroids and the Nasal Ocular Response". Eye symptoms of tearing, redness and itch frequently occur in patients with allergic rhinitis or hayfever. The purpose of this study is to learn whether placing allergen (the substance that causes allergies) in the nose several days in a row will cause an increase in eye symptoms and whether receivi...

What is the current status of trial NCT00473915?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2007-04. Estimated completion is 2008-02.

What conditions does trial NCT00473915 study?

This clinical trial studies the following conditions: Seasonal Allergic Rhinitis.

What interventions are being tested in trial NCT00473915?

The interventions under investigation include: fluticasone furoate (DRUG).

Who is sponsoring clinical trial NCT00473915?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00473915 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Seasonal Allergic Rhinitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00473915's enrollment target sits among peer trials

20 17th of 16 the lowest of 16 other Seasonal Allergic Rhinitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Seasonal Allergic Rhinitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00473915, the US trial registry maintained by the National Library of Medicine. NCT00473915 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.